Zimmer Biomet Holdings ZBH
NYSE ZBH
$92.43 -2.18 (-2.30%)
As of: Sep 10, 2026 · 3:59 PM EDT

Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026)

Zimmer Biomet Holdings (ZBH) posted Total Non-Current Liabilities of $9.5 billion for Q2 2026, up 1.25% on a QoQ basis from $9.4 billion in Q1 2026, and up 0.79% year-over-year from $9.5 billion in Q2 2025.

Analysis

Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings has reported Total Non-Current Liabilities for 18 years, with the latest figure at $9.5 billion in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 0.79% year-over-year to $9.5 billion in Q2 2026; TTM through Jun 2026 was $9.5 billion, a 0.79% increase from a year earlier, with the FY2025 full-year figure at $9.8 billion, up 19.83% from the prior year.
  • Total Non-Current Liabilities was $9.5 billion for Q2 2026 at Zimmer Biomet Holdings, up from $9.4 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $9.9 billion in Q3 2025, with the low at $7.6 billion in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $8.7 billion, with a median of $8.5 billion recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities slipped 20.83% in 2022, then gained 24.94% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $8.4 billion in 2022, then fell by 3.85% to $8.1 billion in 2023, then gained by 0.77% to $8.1 billion in 2024, then increased by 19.83% to $9.8 billion in 2025, then decreased by 2.39% to $9.5 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $9.5 billion (Q2 2026), $9.4 billion (Q1 2026), and $9.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 40.46 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 2.57 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 3.68 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 3.44 Bn
10 Zimmer Biomet Holdings 17.73 Bn 17.32 Bn 1.54 Bn 9.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.53 Bn
Mar 31, 2026 9.41 Bn
Dec 31, 2025 9.76 Bn
Sep 30, 2025 9.92 Bn
Jun 30, 2025 9.45 Bn
Mar 31, 2025 8.87 Bn
Dec 31, 2024 8.15 Bn
Sep 30, 2024 8.31 Bn
Jun 30, 2024 7.57 Bn
Mar 31, 2024 8.27 Bn
Dec 31, 2023 8.08 Bn
Sep 30, 2023 8.07 Bn
Jun 30, 2023 8.27 Bn
Mar 31, 2023 8.45 Bn
Dec 31, 2022 8.41 Bn
Sep 30, 2022 8.47 Bn
Jun 30, 2022 8.74 Bn
Mar 31, 2022 9.00 Bn
Dec 31, 2021 10.21 Bn
Sep 30, 2021 10.69 Bn